Literature DB >> 11186304

Host factors influencing viral persistence.

A R Thomsen1, A Nansen, S O Andreasen, D Wodarz, J P Christensen.   

Abstract

With the aim of characterizing the antiviral immune response to a non-cytocidal virus, we studied the outcome of lymphocytic choriomeningitis virus infection in a number of gene knockout mouse strains. Two virus strains differing markedly in their capacity to spread and replicate inside the murine host were used. Our results reveal that very different outcomes may be observed depending on virus strain and immunocompetence of the host. Thus while CD4+ cells are not critical during the initial phase of virus control, infectious virus reappear in mice lacking CD4+ cells, B cells or CD40 ligand. Reappearance of virus is associated with impaired long-term CD8+ T-cell mediated immune surveillance, and the time to virus resurgence is inversely correlated to the replication rate of the virus. Our studies also reveal that interferon-gamma is a central cytokine, and depending on the rate of virus replication, mice lacking the ability to produce interferon-gamma may develop either a severe, mostly fatal, T-cell mediated wasting syndrome or a chronic infection characterized by long-term coexistence of antiviral cytotoxic T lymphocytes and infectious virus. Mathematical modelling indicates that these different outcomes may be explained in relatively simple mathematical terms. This suggests that modelling may be used as a means to predict critical host and virus parameters. Therefore, combining mathematical modelling with precise, quantitative, in vivo analyses looks to be a promising approach in addressing central quantitative issues in immunobiology.

Entities:  

Mesh:

Year:  2000        PMID: 11186304      PMCID: PMC1692806          DOI: 10.1098/rstb.2000.0640

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  78 in total

1.  A new analysis of allogeneic interactions.

Authors:  K J Lafferty; A J Cunningham
Journal:  Aust J Exp Biol Med Sci       Date:  1975-02

2.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

Authors:  J P Ridge; F Di Rosa; P Matzinger
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

Review 3.  CD40 and CD154 in cell-mediated immunity.

Authors:  I S Grewal; R A Flavell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  High-dose survival in the lymphocytic choriomeningitis virus infection is accompanied by suppressed DTH but unaffected T-cell cytotoxicity.

Authors:  O Marker; A R Thomsen; M Volkert; B L Hansen; I H Clemmensen
Journal:  Scand J Immunol       Date:  1985-01       Impact factor: 3.487

Review 5.  Cellular requirements for the induction of cytotoxic T cells in vitro.

Authors:  W F Davidson
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

6.  Persistent LCM virus infection in the mouse. Immunity and tolerance.

Authors:  M Volkert; K Bro-Jorgensen; O Marker
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

7.  The interplay between target organ concentrations of lymphocytic choriomeningitis virus and cell mediated immunity in baby mice.

Authors:  O Marker; G Thorner Andersen; M Volkert
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-02

8.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

Authors:  S R Bennett; F R Carbone; F Karamalis; R A Flavell; J F Miller; W R Heath
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

9.  Immunological unresponsiveness of nude mice to LCM virus infection.

Authors:  P J Christoffersen; M Volkert; J Rygaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

10.  Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice.

Authors:  O Marker; M Volkert
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  9 in total

1.  Antigen location contributes to the pathological features of a transplanted heart graft.

Authors:  Yifa Chen; Yilmaz Demir; Anna Valujskikh; Peter S Heeger
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  Conditions for pathogen elimination by immune systems.

Authors:  José Guilherme Chaui-Berlinck; José Alexandre Marzagão Barbuto; Luiz Henrique Alves Monteiro
Journal:  Theory Biosci       Date:  2004-09       Impact factor: 1.919

3.  B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection.

Authors:  Ichiro Misumi; Jason K Whitmire
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

Review 4.  Modeling T cell responses to antigenic challenge.

Authors:  Dominik Wodarz
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-01       Impact factor: 2.745

5.  Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Authors:  Courtney Dow; Carla Oseroff; Bjoern Peters; Courtney Nance-Sotelo; John Sidney; Michael Buchmeier; Alessandro Sette; Bianca R Mothé
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

6.  Virus dynamics in the presence of synaptic transmission.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Math Biosci       Date:  2013-01-25       Impact factor: 2.144

7.  Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.

Authors:  Rong Ou; Menghua Zhang; Lei Huang; Demetrius Moskophidis
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 8.  Biomechanics of T Cell Dysfunctions in Chronic Diseases.

Authors:  Sachith D Gunasinghe; Newton G Peres; Jesse Goyette; Katharina Gaus
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 9.  Host cell factors as antiviral targets in arenavirus infection.

Authors:  Florencia N Linero; Claudia S Sepúlveda; Federico Giovannoni; Viviana Castilla; Cybele C García; Luis A Scolaro; Elsa B Damonte
Journal:  Viruses       Date:  2012-09-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.